Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

3rd Annual Stability Testing Conference

Next-Gen Sequencing Trends 2009

Competitor Analysis: c-MET/HGF Inhibitors

The Japanese Pharmaceutical Market 2008-2023

New Products

Japanese Pharmaceutical Market 2009-2024

3rd Annual Lyophilisation Conference

The Global Bioinformatics Market: Market size, forecasts and company profiles

Pharmaceutical Mergers and Acquisitions (PH133)

Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value

Strategic Clinical Sourcing (PH125)) Managing Costs and CROs

The Global Analgesics Market 2009-2024

Competitor Analysis: Coagulation Factors

Competitor Analysis: PDGF-R Agonists and Antagonists

World Market for Addiction Disorders, 2009-2016

BioPortfolio | Kalorama Reports | Anti-Infectives World Market 2nd Edition Vol III Antivirals

Anti-Infectives World Market 2nd Edition Vol III Antivirals

This third volume of Kalorama Information’s World Market for Anti-Infectives series, the 2nd. Edition focuses on three general product segments of antiviral treatment:

Nucleoside Analogs

Protease Inhibitors

Other Misc. Antivirals

The report covers both currently marketed and late stage development antiviral products in detail. For each segment, the report provides:

Revenue Data by Infection Type

An overview of products on the market

Review of products in the development pipeline

Market estimates and forecasts through 2011

Market segmentation by geographic region

Market share of leading suppliers

Market share of leading products

The report also includes statistical (epidemiologic and demographic) information for viral infections by type worldwide, with special emphasis on the United States and describes the major clinical, business, and regulatory trends shaping the global and domestic markets.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. In addition, Kalorama Information conducted interviews with key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives.

All market data pertains to the world market at the manufacturers’ level as of 2006. Compound annual growth rates (CAGRs) are provided for 2006-2011 periods for each industry segment covered. Competitive analysis is provided for the year 2006. The forecasted market analysis for 2006-2011 was based on probability of approval and sales of products in late stage development, product marketing, and demographic trends.

May 1, 2007

168 Pages

PDF Format
Table of Contents
Price: $2,995.00 / €2,003.66

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions